The global companion animal osteoarthritis market forecast highlights significant growth opportunities as veterinary healthcare continues to evolve rapidly. Osteoarthritis is becoming one of the most common chronic conditions affecting aging companion animals, particularly dogs and cats. Rising pet ownership, increasing pet humanization, and growing investment in advanced veterinary treatments are driving strong market demand worldwide.

According to Polaris Market Research, the global companion animal osteoarthritis market was valued at USD 2.26 billion in 2024 and is projected to reach USD 18.45 billion by 2034, registering a CAGR of 23.4% from 2025 to 2034. This impressive growth reflects the increasing focus on companion animal wellness, chronic disease management, and innovative orthopedic therapies.

The companion animal osteoarthritis market forecast is strongly influenced by the increasing lifespan of pets. Older animals are more vulnerable to joint degeneration, mobility issues, and chronic pain conditions, which creates a sustained need for long-term treatment solutions. Veterinary clinics and pet owners are increasingly prioritizing early diagnosis and proactive treatment strategies to improve the quality of life for aging animals.

One of the most important trends supporting the companion animal osteoarthritis market is the growing adoption of biologics. Polaris Market Research states that the biologics segment accounted for approximately 54% of the revenue share in 2024 due to its ability to address the underlying causes of osteoarthritis instead of only relieving symptoms. Stem cell therapy, platelet-rich plasma (PRP), and monoclonal antibodies are gaining popularity because they offer regenerative benefits and improved long-term mobility outcomes.

The canine segment held the largest revenue share in 2024 because osteoarthritis is highly prevalent among aging and large-breed dogs. Pet owners are increasingly willing to invest in advanced therapies and mobility treatments to improve canine health and comfort. The emotional bond between owners and pets continues to support higher spending on veterinary healthcare services, contributing significantly to market expansion.

Another factor strengthening the companion animal osteoarthritis market forecast is the increasing availability of advanced orthopedic procedures. Veterinary medicine is rapidly evolving with innovations such as arthroscopy, corrective surgeries, joint replacement procedures, and regenerative medicine therapies. These technologies are improving treatment outcomes while expanding opportunities for veterinary specialists and healthcare providers.

Improved imaging technologies and diagnostic tools are also contributing to market growth. Early detection of joint degeneration allows veterinarians to begin treatment sooner, improving disease management and reducing long-term complications. Advanced imaging systems and minimally invasive diagnostics are helping veterinary professionals provide more accurate and personalized treatment plans for pets suffering from osteoarthritis.

Read More @ https://www.polarismarketresearch.com/industry-analysis/companion-animal-osteoarthritis-market

The injectable segment accounted for the largest revenue share in 2024 due to its rapid onset of action and long-lasting pain relief. Injectable biologics and regenerative therapies are becoming increasingly popular for moderate-to-severe osteoarthritis cases where fast symptom management is essential. Veterinarians often prefer injectable solutions when oral medication compliance is difficult or when quicker therapeutic results are required.

North America dominated the companion animal osteoarthritis market in 2024 due to advanced veterinary infrastructure, high pet healthcare spending, and strong awareness regarding chronic joint conditions in companion animals. The region benefits from a well-established veterinary care ecosystem and widespread adoption of innovative treatment technologies.

Meanwhile, Asia Pacific is expected to witness substantial growth from 2025 to 2034 due to rising pet ownership, urbanization, and increasing awareness about animal health. Expanding veterinary services and growing disposable incomes are encouraging pet owners across the region to seek advanced osteoarthritis treatments for companion animals.

The e-commerce segment is also projected to register the highest CAGR during the forecast period. Online platforms are making it easier for pet owners to access medications, supplements, and therapeutic products conveniently. Subscription services, tele-veterinary consultations, and digital healthcare solutions are improving accessibility and supporting long-term market growth.

As veterinary medicine continues to advance, the companion animal osteoarthritis market forecast remains highly positive. The combination of technological innovation, growing pet healthcare awareness, and rising demand for advanced therapies is expected to drive sustained market expansion over the next decade.

More Trending Latest Reports By Polaris Market Research:

Property Management Software Market

Video Analytics Market

Edge AI market

Pharmaceutical Contract Development & Manufacturing Organization Market

Europe Subcutaneous Immunoglobulin Market

Kyphoplasty Market

Obesity Treatment Market

Quillaia Extracts Market

Automation Testing Market